No evidence for sex differences in the severity and treatment of cancer pain Janet M. Edrington, RN, MS, Steven Paul, PhD, Marylin Dodd, RN, PhD, Claudia West, RN, MS, Noreen Facione, RN, PhD, Debu Tripathy, MD, Peter Koo, PharmD, Karen Schumacher, RN, PhD, Christine Miaskowski, RN, PhD Journal of Pain and Symptom Management Volume 28, Issue 3, Pages 225-232 (September 2004) DOI: 10.1016/j.jpainsymman.2003.12.013
Figure 1 Male (n=57) and female (n=130) patients' ratings of least, average, and worst pain intensity scores using a 0 (no pain) to 10 (excruciating) numeric rating scale. Bar graphs indicate values as the mean ± standard deviations. Journal of Pain and Symptom Management 2004 28, 225-232DOI: (10.1016/j.jpainsymman.2003.12.013)
Figure 2 Total dose of opioid prescribed (a) and taken (b) by male (n=57) and female (n=130) patients, expressed as milligrams of oral morphine equivalents per day, oncology outpatients with pain from bone metastasis. Bar graphs indicate values as the mean ± standard deviations. Journal of Pain and Symptom Management 2004 28, 225-232DOI: (10.1016/j.jpainsymman.2003.12.013)
Figure 3 Total medication quantification scale score prescribed (a) and taken (b) by male (n=57) and female (n=130) oncology outpatients with pain from bone metastasis. Bar graphs indicate values as the mean ± standard deviations. Journal of Pain and Symptom Management 2004 28, 225-232DOI: (10.1016/j.jpainsymman.2003.12.013)